Overview
Teimuraz Apridonidze is a Cardiologist in Manchester,, New Hampshire. Dr. Apridonidze is rated as an Experienced provider by MediFind in the treatment of Pulmonary Veno-Occlusive Disease. His top areas of expertise are Pediatric Myocarditis, Atrial Fibrillation, Aortic Regurgitation, and Heart Failure with Preserved Ejection Fraction (HFpEF).
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- MANAGED MEDICAID PLAN
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 Hitchcock Way, Manchester,, NH 03104
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brigham And Women's Hospital, Heart And Vascular Center
Dr. Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.After receiving his medical degree from Yale University School of Medicine, Dr. Waxman completed a residency in internal medicine at Yale New Haven Hospital. He then completed two fellowships: the first at Howard Hughes Medical Institute, and the second in pulmonary and critical care at Yale New Haven Hospital. He is board certified in critical care medicine, internal medicine and pulmonary disease.Dr. Waxman’s clinical interests include pulmonary arterial hypertension (PAH), right heart failure, thromboembolic disease and pulmonary vascular disease. His research focuses on the inflammatory mechanisms of pulmonary vascular remodeling that lead to right heart failure. His research into the regulation of cell death proteins by IL-6 cytokines in mice led to the discovery of a relationship between dyspnea and mitochondrial dysfunction, and resulted in additional clinical studies examining the abnormalities of inflammatory mediators and oxygen extraction in patients with PAH. He has authored over 110 peer-reviewed publications and has received funding from the National Institutes of Health and the National Heart, Lung, and Blood Institute. Dr. Waxman is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Veno-Occlusive Disease. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Interstitial Lung Disease, Lung Transplant, and Thrombectomy.
UMass Memorial Children's Medical Center
Theo Meyer is a Cardiologist in Worcester,, Massachusetts. Dr. Meyer is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Veno-Occlusive Disease. His top areas of expertise are Heart Failure, Cardiomyopathy, Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiac Ablation, and Pacemaker Implantation.
Emerson Health Cardiology
Benjamin Tillinger is a Cardiologist in Concord, Massachusetts. Dr. Tillinger is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Veno-Occlusive Disease. His top areas of expertise are Adenosine Deaminase 2 Deficiency, Coronary Heart Disease, Arrhythmias, and Heart Failure with Preserved Ejection Fraction (HFpEF).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Aortic RegurgitationDr. Apridonidze isDistinguished. Learn about Aortic Regurgitation.
- Atrial FibrillationDr. Apridonidze isDistinguished. Learn about Atrial Fibrillation.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- Pediatric MyocarditisDr. Apridonidze isDistinguished. Learn about Pediatric Myocarditis.
- Advanced
- Adenosine Deaminase 2 DeficiencyDr. Apridonidze isAdvanced. Learn about Adenosine Deaminase 2 Deficiency.
- AnginaDr. Apridonidze isAdvanced. Learn about Angina.
- Aortic Valve StenosisDr. Apridonidze isAdvanced. Learn about Aortic Valve Stenosis.
- ApoplexyDr. Apridonidze isAdvanced. Learn about Apoplexy.
- AtherosclerosisDr. Apridonidze isAdvanced. Learn about Atherosclerosis.
- Coronary Heart DiseaseDr. Apridonidze isAdvanced. Learn about Coronary Heart Disease.
- Experienced
- ArrhythmiasDr. Apridonidze isExperienced. Learn about Arrhythmias.
- Arterial EmbolismDr. Apridonidze isExperienced. Learn about Arterial Embolism.
- Atrial TachycardiaDr. Apridonidze isExperienced. Learn about Atrial Tachycardia.
- Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
- Bidirectional TachycardiaDr. Apridonidze isExperienced. Learn about Bidirectional Tachycardia.
- Brugada SyndromeDr. Apridonidze isExperienced. Learn about Brugada Syndrome.

